CAR-T cells with CD28 costimulatory domain were able to achieve faster tumor eradication within the first 7 days when the dose was reduced to levels below the therapeutic dose (4×105, 2×105 and 1×105 CAR-T cells). Here, CD28 is linked to neoplasm.